EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparative study between novel sedative drug (dexmedetomidine) versus midazolam–propofol for conscious sedation in pediatric patients undergoing oro-dental procedures

Waleed M.A. Al Taher, Emad E. Mansour, Mohamed N. El Shafei

Egyptian Journal of Anaesthesia · 2010

DOI: 10.1016/j.egja.2010.04.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Egyptian Journal of Anaesthesia, 2010. Verfasst von Waleed M.A. Al Taher und 2 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ObjectiveA comparative study to evaluate the effect of dexmedetomidine as a sedative in pediatric dental patients in comparison to the currently used combination of midazolam and propofol.MethodsSixty ASA I children (4–10 years old) referred from the outpatient clinic of the pediatric dentistry department for sedation for dental procedures. They were randomly classified into two groups, group I (dexmedetomidine group) was given as 2 μg/kg loading dose over 5 min followed by 0.4 μg/kg/h continuous infusion. Group II (midazolam–propofol group) midazolam was given as 0.05 mg/kg and propofol was given loading dose as 1 mg/kg over 5 min followed by 5 mg/kg/h continuous infusion. Heart rate, mean arterial blood pressure, oxygen saturation, respiratory rate were recorded every 5 min till discharge. The onset of sedation, procedure time, recovery time, discharge time and the need of analgesia were recorded. The incidence of occurrence of adverse effects was observed.ResultsIn group I, the mean onset of sedation was significantly longer than in group II, but recovery time was significantly shorter in group I than group II, there are significantly hemodynamics effects in the first 15 min and more incidence of occurrence of side effects in group II than group I. There are more analgesic effects of dexmedetomidine in group I than group II postoperatively.ConclusionDexmedetomidine is safe and effective when used for sedation in pediatric patients undergoing dental procedures.

Zitieren

APA

Taher, W. M. A., Mansour, E. E., & Shafei, M. N. E. (2010). Comparative study between novel sedative drug (dexmedetomidine) versus midazolam–propofol for conscious sedation in pediatric patients undergoing oro-dental procedures. Egyptian Journal of Anaesthesia. https://doi.org/10.1016/j.egja.2010.04.002

Vancouver

Taher WMA, Mansour EE, Shafei MNE. Comparative study between novel sedative drug (dexmedetomidine) versus midazolam–propofol for conscious sedation in pediatric patients undergoing oro-dental procedures. Egyptian Journal of Anaesthesia. 2010. doi:10.1016/j.egja.2010.04.002

BibTeX
@article{Taher2010,
  author = {Taher, Waleed M.A. Al and Mansour, Emad E. and Shafei, Mohamed N. El},
  title = {Comparative study between novel sedative drug (dexmedetomidine) versus midazolam–propofol for conscious sedation in pediatric patients undergoing oro-dental procedures},
  journal = {Egyptian Journal of Anaesthesia},
  year = {2010},
  doi = {10.1016/j.egja.2010.04.002}
}
Kostenlos starten →